Correspondence 0001104659-23-112242 from AVENUE THERAPEUTICS, INC. (ATXI) (CIK 0001644963) (ATXI)
AVENUE THERAPEUTICS, INC. (ATXI) (CIK 0001644963)
Date: Oct. 27, 2023 · CIK: 0001644963 · Accession: 0001104659-23-112242
AI Filing Summary & Sentiment
File numbers found in text: 333-274562
Letter
Avenue Therapeutics, Inc.
1111 Kane Concourse, Suite 301
Bay Harbor Islands, Florida 33154
VIA EDGAR
October 27, 2023
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attn: Joshua Gorsky
Re: Avenue Therapeutics, Inc.
Registration Statement on Form S-1 (Reg. No. 333-274562)
Request for Acceleration of Effective Date
Ladies and Gentlemen:
Reference is made to our letter, filed as correspondence with the U.S. Securities and Exchange Commission via EDGAR on October 24, 2023, in which we requested the acceleration of the effective date of the above-captioned Registration Statement to 5:30 p.m. Eastern time on October 25, 2023, which request was subsequently modified by the Company’s counsel to request that the Registration Statement be declared effective as of 9:30 a.m. Eastern time on October 27, 2023. We are no longer requesting that the Registration Statement be declared effective at that date and time, and we hereby formally withdraw our prior request for acceleration of the effective date of the above-referenced Registration Statement.
Thank you for your assistance in this matter.
Very
truly yours,
Avenue
Therapeutics, Inc.
Show Raw Text
CORRESP
1
filename1.htm
Avenue Therapeutics, Inc.
1111 Kane Concourse, Suite 301
Bay Harbor Islands, Florida 33154
VIA EDGAR
October 27, 2023
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attn: Joshua Gorsky
Re:
Avenue Therapeutics, Inc.
Registration Statement on Form S-1 (Reg. No.
333-274562)
Request for Acceleration of Effective Date
Ladies and Gentlemen:
Reference is made to our letter, filed as correspondence
with the U.S. Securities and Exchange Commission via EDGAR on October 24, 2023, in which we requested the acceleration of the effective
date of the above-captioned Registration Statement to 5:30 p.m. Eastern time on October 25, 2023, which request was subsequently modified
by the Company’s counsel to request that the Registration Statement be declared effective as of 9:30 a.m. Eastern time on October
27, 2023. We are no longer requesting that the Registration Statement be declared effective at that date and time, and we hereby formally
withdraw our prior request for acceleration of the effective date of the above-referenced Registration Statement.
Thank you for your assistance in this matter.
Very
truly yours,
Avenue
Therapeutics, Inc.
/s/
Alexandra MacLean
Name:
Alexandra
MacLean
Title:
Chief
Executive Officer
cc (via email):
Rakesh Gopalan and David Wolpa, McGuireWoods LLP
Barry Grossman, Sarah Williams, Matthew Bernstein,
Ellenoff Grossman & Schole LLP
Eric Cheng, Maxim Group LLC